CONTEXT THERAPEUTICS INC. Financing Cash Flow
CONTEXT THERAPEUTICS INC. (CNTX) reported Financing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2025 was -$15.27K, a 100.01% decline from fiscal 2024.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2024 was $109.29M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2023 was $0.00.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2022 was -$102.07K, a 100.17% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | -$15.27K 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | -$15.27K 10-Q · filed 2025-11-05 | $14.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$15.27K 10-Q · filed 2026-08-05 | $14.52M derived: sum of 3 quarters · filed 2026-08-05 | $14.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$15.27K 10-Q · filed 2026-05-06 | $14.52M derived: sum of 2 quarters · filed 2026-05-06 | $14.48M derived: sum of 3 quarters · filed 2026-05-06 | $109.28M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $14.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $14.49M derived: sum of 2 quarters · filed 2026-03-23 | $109.29M derived: sum of 3 quarters · filed 2026-03-23 | $109.29M 10-K · filed 2026-03-23 |
| 2024-09-30 | -$44.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $94.76M derived: sum of 2 quarters · filed 2025-11-05 | $94.76M 10-Q · filed 2025-11-05 | $94.76M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $94.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $94.80M 10-Q · filed 2025-08-06 | $94.80M derived: sum of 3 quarters · filed 2025-08-06 | $94.80M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-05-07 | $0.00 derived: sum of 3 quarters · filed 2025-05-07 | $0.00 derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-08-07 | $0.00 derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | -$102.07K 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$102.07K 10-Q · filed 2023-11-09 | $54.13M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$102.07K 10-Q · filed 2023-08-09 | $54.13M derived: sum of 3 quarters · filed 2023-08-09 | $53.31M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$102.07K 10-Q · filed 2023-05-10 | $54.13M derived: sum of 2 quarters · filed 2023-05-10 | $53.31M derived: sum of 3 quarters · filed 2023-05-10 | $55.26M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $54.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $53.41M derived: sum of 2 quarters · filed 2023-03-22 | $55.36M derived: sum of 3 quarters · filed 2023-03-22 | $58.39M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$816.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.13M derived: sum of 2 quarters · filed 2022-11-09 | $4.17M 10-Q · filed 2022-11-09 | $4.52M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $4.98M 10-Q · filed 2022-08-11 | $5.33M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $3.03M 10-Q · filed 2022-05-11 | $3.38M derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.15M 10-K · filed 2022-03-23 | ||
| 2020-09-30 | $799.05K 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |